title: A fingerprint pair analysis of hERG inhibition data.
abstract: BACKGROUND
  Drugs that bind to the human Ether-a-go-go Related Gene (hERG) potassium channel and block its ion conduction can lead to Torsade de Pointes (TdP), a fatal ventricular arrhythmia. Thus, compounds are screened for hERG inhibition in the drug development process; those found to be active face a difficult road to approval. Knowing which structural transformations reduce hERG binding would be helpful in the lead optimization phase of drug discovery.
  
  
  RESULTS
  To identify such transformations, we carried out a comprehensive analysis of all approximately 33,000 compound pairs in the Novartis internal database which have IC50 values in the dofetilide displacement assay. Most molecular transformations have only a single example in the data set; however, a few dozen transformations have sufficient numbers for statistical analysis.
  
  
  CONCLUSIONS
  We observe that transformations which increased polarity (for example adding an oxygen, or an sp2 nitrogen), decreased lipophilicity (removing carbons), or decreased positive charge consistently reduced hERG inhibition between 3- and 10-fold. The largest observed reduction in hERG was from a transformation from imidazole to methyl tetrazole. We also observe that some changes in aromatic ring substituents (for example hydrogen to methoxy) can also reduce hERG binding in vitro.
authors.affiliation: Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, MA 02139, USA. Clayton.springer@novartis.com.
authors.forename: Clayton
authors.initials: C
authors.lastname: Springer
authors.forename: Katherine L
authors.initials: KL
authors.lastname: Sokolnicki